Daniel A. Muruve
Medical Director of the Alberta Kidney Care - South
Postdoctoral Training - Renal
Research Fellowship, Immunology
Research and teaching
Dr. Muruve’s research expertise is in the areas of innate immunity, inflammation and kidney disease. Currently, his research program examines the role of the innate immune system, with a specific focus on the NLR (Nod-like receptor) family of proteins and inflammasomes in the biology of disease, including acute and chronic kidney diseases. The cellular and molecular biology of the renal epithelium and the role of the immune system in kidney injury and fibrosis are significant interests in the laboratory. Dr. Muruve has also led the establishment of a precision medicine and translational research program for kidney and glomerular diseases. Dr. Muruve is the Director of the Biobank for the Molecular Classification of Kidney Disease that provides a direct link to clinical patient samples as well as a clinicopathologic database to enable translational research in biomarkers, molecular epidemiology and genetics in kidney disease
Daniel A. Muruve is a Professor of Medicine in the Department of Medicine at the University of Calgary. He is a member of the Immunology Research Group in the Snyder Institute for Chronic Diseases. Dr. Muruve is also a practicing nephrologist in the Calgary zone of Alberta Health Services. He is the Section Chief for Nephrology in the Department of Medicine, University of Calgary and Medical Director of the Alberta Kidney Care - South for Alberta Health Services.
Dr. Muruve graduated with an MD degree from the University of Manitoba in 1989. He did his post-graduate medical training at numerous Universities including a Renal Fellowship at the Beth Israel Deaconess Medical Centre, Harvard University in Boston, MA, USA. Following the completion of his medical training, he completed a Research Fellowship in Immunology at the Beth Israel Deaconess Medical Centre, Harvard Institutes of Medicine.